[Gout and Its Management in Clinical Practice].

Area of Science:

• Rheumatology
• Clinical Medicine
• Pharmacology

Background:

• Gout management focuses on acute attack relief and preventing complications.
• Hyperuricemia is a key factor in recurrent gout attacks and associated morbidities.
• Accurate diagnosis is crucial for effective treatment strategies.

Purpose of the Study:

• To outline current clinical practices for gout diagnosis and management.
• To emphasize the importance of long-term hyperuricemia control.
• To recommend therapeutic targets for uric acid levels.

Main Methods:

• Diagnosis relies on crystal identification in synovial fluid via polarized light microscopy.
• High-resolution ultrasonography is a valuable imaging tool.
• Treatment includes NSAIDs, steroids, and colchicine for acute attacks.

Main Results:

• Long-term management necessitates hypouricemic therapy to prevent recurrent gout.
• Target serum uric acid level should be <360 µmol/l (<6 mg/dl).
• Xanthine oxidase inhibitors are the preferred first-line hypouricemic agents.

Conclusions:

• Comprehensive gout care requires addressing both acute symptoms and underlying hyperuricemia.
• Regular monitoring and adjustment of hypouricemic therapy are essential for achieving treatment goals.
• Effective management reduces the risk of renal, cardiac, and metabolic complications.